Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.

@article{Arora2015CenterFI,
  title={Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort.},
  author={Mukta Arora and Michael T. Hemmer and Kwang Woo Ahn and John P. Klein and Corey S Cutler and {\'A}lvaro Urbano-Isp{\'i}zua and Daniel Couriel and Amin Majid Alousi and Robert Peter Gale and Yoshihiro Inamoto and Daniel J. Weisdorf and Peigang Li and Joseph H Antin and Brian James Bolwell and Michael Boyiadzis and J Y Cahn and Mitchell S Cairo and Luis M. Isola and David A. Jacobsohn and Madan H. Jagasia and Thomas R. Klumpp and Effie W. Petersdorf and Stella Santarone and Harry C. Schouten and John R Wingard and Stephen R. Spellman and Steven Z Pavletic and Stephanie J Lee and Mary M. Horowitz and Mary E D Flowers},
  journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation},
  year={2015},
  volume={21 4},
  pages={640-5}
}
We previously reported a risk score that predicted mortality in patients with chronic graft-versus-host disease (CGVHD) after hematopoietic stem cell transplantation (HCT) between 1995 and 2004 and reported to the Center for International Blood and Marrow Transplant Research (CIBMTR). We sought to validate this risk score in an independent CIBMTR cohort of… CONTINUE READING